OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Andrew Feilden is the European E&L strategic director for Element.
August 03, 2022
A comprehensive understanding of potential material change can mitigate its impact on patient safety.
July 02, 2022
By understanding potential material change, the impact on patient safety can be understood and mitigated.